Adverse Event Reporting in Clinical Trials In 2023, the FDA banned 19 peptides from compounding pharmacies. No specific safety incident. No clear signal. Just a regulatory decision that pushed millions of patients toward gray market suppliers and overseas Population Scale Identification of Differential Adverse Events Before and During a Pandemic Zitnik Lab A pharmacovigilance datadriven approach to reveal high fatal adverse events following checkpoint immunotherapy PNAS